Breaking News Instant updates and real-time market news.

NTNX

Nutanix

$32.68

-1.02 (-3.03%)

08:00
05/31/19
05/31
08:00
05/31/19
08:00

Nutanix price target lowered to $46 from $63 at Needham

Needham analyst Jack Andrews lowered his price target on Nutanix to $46 after its "mixed" Q3 results saw a beat on earnings and gross margins and a miss on revenue and billings. The analyst notes that the accelerated shift to term-based licenses "accentuated the compression of billings and revenue" as up-front recognition of revenues was reduced, even though he sees the impact of the transition as "incremental" in terms of the company's "lead generation, go-to-market of new products, and changes to the sales organization." Based on his view of continued robust demand for Nutanix's HCI and cloud-based services, Andrews keeps his Buy rating.

  • 05

    Jun

  • 10

    Jun

  • 09

    Jul

NTNX Nutanix
$32.68

-1.02 (-3.03%)

05/31/19
JEFF
05/31/19
NO CHANGE
Target $40
JEFF
Buy
Nutanix price target lowered to $40 from $49 at Jefferies
In a post-earnings research note titled "Some Things Better Done in Private," Jefferies analyst John DiFucci lowered his price target for Nutanix to $40 from $49. The company reminded us last night why some companies go private before embarking on a major model/business transition, DiFucci writes, after it missed fiscal Q3 estimates and guidance Q4 down. The analyst, however, keeps a Buy rating on the shares.
05/31/19
STFL
05/31/19
NO CHANGE
Target $25
STFL
Hold
Nutanix price target lowered to $25 from $39 at Stifel
Stifel analyst Brad Reback lowered his price target for Nutanix to $25 from $39 saying the company last night reported a "disappointing" quarter and guidance. The company's execution is "uneven" as its subscription transition weighs on results, Reback tells investors in a research note. While shares are "not expensive," Nutanix remains in the "penalty box" and it will take several more quarters to evaluate progress, says the analyst, who keeps a Hold rating on the shares.
05/31/19
PIPR
05/31/19
DOWNGRADE
Target $28
PIPR
Neutral
Piper downgrades Nutanix to Neutral on 'continued execution issues'
Piper Jaffray analyst Andrew Nowinski downgrade Nutanix to Neutral from Overweight and cut his price target for the shares to $28 from $47. The analyst cites the company's "continued execution issues," which he attributes partially to increasing competition, for the downgrade following Nutanix's revenue miss in fiscal Q3. The analyst says that while the valuation at these levels looks attractive, he wants to wait for revenue growth to stabilize before getting more constructive.
05/31/19
BTIG
05/31/19
NO CHANGE
Target $40
BTIG
Buy
Nutanix price target lowered to $40 from $50 at BTIG
BTIG analyst Edward Parker lowered his price target on Nutanix to $40 after its Q3 results, saying the "growing pains" were again visible in the quarter after an "exceptionally poor outlook" provided by the management following Q2. The analyst attributes the underperformance to the headwinds related to the company's accelerated transition to subscription-based revenues and says the results were "disappointing" relative to its prior messaging and channel checks. Parker keeps his Buy rating on the stock however, saying Nutanix has a "strong positioning in a two-horse race" within a hot market.

TODAY'S FREE FLY STORIES

AGN

Allergan

$129.65

-1.32 (-1.01%)

, ABBV

AbbVie

$78.41

-0.37 (-0.47%)

06:28
06/25/19
06/25
06:28
06/25/19
06:28
Periodicals
Breaking Periodicals news story on Allergan, AbbVie »

AbbVie would pay $188 per…

AGN

Allergan

$129.65

-1.32 (-1.01%)

ABBV

AbbVie

$78.41

-0.37 (-0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

AGN

Allergan

$129.65

-1.32 (-1.01%)

, ABBV

AbbVie

$78.41

-0.37 (-0.47%)

06:27
06/25/19
06/25
06:27
06/25/19
06:27
Periodicals
Breaking Periodicals news story on Allergan, AbbVie »

AbbVie near deal to…

AGN

Allergan

$129.65

-1.32 (-1.01%)

ABBV

AbbVie

$78.41

-0.37 (-0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

PT

Pintec Technology

$2.98

-0.13 (-4.18%)

06:27
06/25/19
06/25
06:27
06/25/19
06:27
Hot Stocks
Pintec Technology announces strategic partnership with Bank of Ganzhou »

Pintec Technology inked a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDY

Dr. Reddy's

$36.08

-0.12 (-0.33%)

06:24
06/25/19
06/25
06:24
06/25/19
06:24
Hot Stocks
Dr. Reddy's launches its Tobramycin Inhalation Solution »

Dr. Reddy's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JD

JD.com

$28.91

-0.17 (-0.58%)

06:21
06/25/19
06/25
06:21
06/25/19
06:21
Periodicals
JD.com's logistics unit raises $218M investment fund, Reuters reports »

The logistics division of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHOP

Shopify

$311.63

-15.05 (-4.61%)

06:19
06/25/19
06/25
06:19
06/25/19
06:19
Downgrade
Shopify rating change  »

Shopify downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

CBMG

Cellular Biomedicine

$15.01

(0.00%)

06:19
06/25/19
06/25
06:19
06/25/19
06:19
Initiation
Cellular Biomedicine initiated  »

Cellular Biomedicine…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTC

Intel

$47.63

0.17 (0.36%)

06:18
06/25/19
06/25
06:18
06/25/19
06:18
Periodicals
Intel plans to cut desktop processor prices by up to 15%, DigiTimes reports »

Intel is planning to cut…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 25

    Jul

LMT

Lockheed Martin

$359.98

0.555 (0.15%)

06:15
06/25/19
06/25
06:15
06/25/19
06:15
Periodicals
U.S.: Turkey would lose F-35 if Russia arms deal moves forward, Reuters says »

The U.S. cannot allow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSANY

Nissan

$0.00

(0.00%)

06:12
06/25/19
06/25
06:12
06/25/19
06:12
Periodicals
Nissan overhauls board following disorderly investor meeting, WSJ reports »

Nissan investors voted to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PVTL

Pivotal Software

$11.35

-0.15 (-1.30%)

06:11
06/25/19
06/25
06:11
06/25/19
06:11
Downgrade
Pivotal Software rating change  »

Pivotal Software…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jul

GOOG

Alphabet

$1,115.75

-6.63 (-0.59%)

, GOOGL

Alphabet Class A

$1,117.00

-8.17 (-0.73%)

06:08
06/25/19
06/25
06:08
06/25/19
06:08
Periodicals
Alphabet's Sidewalk Labs meets resistance over Toronto plans, WSJ reports »

Sidewalk Labs, a unit of…

GOOG

Alphabet

$1,115.75

-6.63 (-0.59%)

GOOGL

Alphabet Class A

$1,117.00

-8.17 (-0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 10

    Jul

  • 25

    Jul

  • 25

    Jul

  • 27

    Oct

LEN

Lennar

$51.41

0.09 (0.18%)

06:07
06/25/19
06/25
06:07
06/25/19
06:07
Earnings
Lennar reports Q2 EPS $1.30, consensus $1.14 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 27

    Jun

  • 28

    Jun

BAS

Basic Energy

$2.43

-0.21 (-7.95%)

06:07
06/25/19
06/25
06:07
06/25/19
06:07
Downgrade
Basic Energy rating change  »

Basic Energy downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

FTSI

FTS International

$5.77

-0.5 (-7.97%)

06:06
06/25/19
06/25
06:06
06/25/19
06:06
Downgrade
FTS International rating change  »

FTS International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMRN

Immuron

$3.00

-0.09 (-2.91%)

06:05
06/25/19
06/25
06:05
06/25/19
06:05
Hot Stocks
Immuron Directors increase shareholdings in the company »

Immuron wishes to advise…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USWS

U.S. Well Services

$5.18

-0.38 (-6.83%)

06:05
06/25/19
06/25
06:05
06/25/19
06:05
Hot Stocks
U.S. Well Services signs agreement with AmeriMex Motor & Controls »

U.S. Well Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMCR

Amcor

$11.14

0.12 (1.09%)

06:03
06/25/19
06/25
06:03
06/25/19
06:03
Hot Stocks
Amcor enters into $394M agreement for sale of three flexible packaging plants »

Amcor announces it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EQT

EQT Corporation

$15.38

0.15 (0.98%)

06:03
06/25/19
06/25
06:03
06/25/19
06:03
Hot Stocks
Rice Team urges EQT Corporation shareholders to vote for Rice Team nominees »

The Rice Team,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

PLL

Piedmont Lithium

$11.50

(0.00%)

06:03
06/25/19
06/25
06:03
06/25/19
06:03
Hot Stocks
Piedmont Lithium announces 47% increase in Piedmont mineral resource estimate »

Piedmont Lithium…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GEN

Genesis Healthcare

$1.23

0.01 (0.82%)

06:03
06/25/19
06/25
06:03
06/25/19
06:03
Periodicals
HUD-backed nursing homes have 'serious deficiencies,' NY Times reports »

Dozens of nursing homes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

VKTX

Viking Therapeutics

$7.94

-0.07 (-0.87%)

06:02
06/25/19
06/25
06:02
06/25/19
06:02
Initiation
Viking Therapeutics initiated  »

Viking Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

CTRP

Ctrip

$36.43

0.37 (1.03%)

06:00
06/25/19
06/25
06:00
06/25/19
06:00
Hot Stocks
Ctrip enters strategic partnership with Tourism Fiji »

Ctrip has signed a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDGL

Madrigal Pharmaceuticals

$101.39

-3.73 (-3.55%)

, VKTX

Viking Therapeutics

$7.94

-0.07 (-0.87%)

05:58
06/25/19
06/25
05:58
06/25/19
05:58
Initiation
Madrigal Pharmaceuticals, Viking Therapeutics, Genfit initiated  »

Madrigal Pharmaceuticals…

MDGL

Madrigal Pharmaceuticals

$101.39

-3.73 (-3.55%)

VKTX

Viking Therapeutics

$7.94

-0.07 (-0.87%)

GNFT

Genfit

$20.19

-0.02 (-0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

  • 27

    Jun

RGEN

Repligen

$81.92

-1.09 (-1.31%)

05:55
06/25/19
06/25
05:55
06/25/19
05:55
Conference/Events
Repligen management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

  • 18

    Sep

  • 19

    Sep

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.